Overview

Detailed Summary

Oxygenta Pharmaceutical Limited, formerly S S Organics Ltd, specializes in manufacturing anti-ulcerative and antibacterial drugs, alongside other pharmaceuticals.
The company engages in both contract manufacturing and independent production, supporting its revenue through strategic partnerships.
Oxygenta's production facilities are situated in Medak, Andhra Pradesh, focusing on bulk drugs, including quinolones, antiasthmatic, and anti-inflammatory medications.
Despite operational challenges, such as the 2015 fire accident, Oxygenta has resumed commercial production to stabilize its operations and market position.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 184 Cr
Volatility: High Risk
P/E Ratio: -10.5
Industry P/E: 33.7
PEG Ratio: —
P/B Ratio: —
52W High: 133.50
52W Low: 45.30

Sales CAGR

1Y: 175.73%
3Y: 21.78%
5Y: 51.45%
10Y: 27.33%

Profit CAGR

1Y: -178.16%
3Y: —
5Y: —
10Y: —

ROE

TTM: 41.16%
3Y: 27.08%
5Y: 13.67%
10Y: 14.73%

ROCE

TTM: -26.02%
3Y: -65.93%
5Y: -30.23%
10Y: -52.67%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BROOKS		66.50	195 Cr	7.95	1.59	0.00	20.04	19.30	16.59
SPML		214.10	188 Cr	14.44	2.64	0.00	18.31	18.42	13.68
OXYGENTAPH		50.19	186 Cr	-10.57	0.00	0.00	41.16	-26.02	-14.69
ANL		255.10	185 Cr	36.79	6.02	0.00	14.29	16.99	12.01
SANJIVIN		149.60	181 Cr	27.02	3.75	0.00	13.87	16.29	7.62
CORALAB		502.50	177 Cr	10.83	0.85	0.00	7.83	10.89	6.81
GUJINJEC		119.90	176 Cr	96.51	14.84	0.00	15.34	21.17	4.96
Median: 7 Co.	—	149.60	185 Cr	14.44	2.64	0.00	15.34	16.99	7.62

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	9.15	11	13	14	33	49	15	14	34	50
Expenses	12	12	14	16	38	51	22	19	38	50
Operating Profit	-2.47	-1.61	-1.78	-2.17	-4.35	-1.68	-6.83	-4.57	-4.08	0.11
OPM %	-26.99	-15.26	-14.10	-15.49	-13.10	-3.40	-45.14	-31.96	-12.02	0.22
Other Income	-0.02	0.26	0.02	0.75	0.49	-0.22	0.16	-0.06	0.00	0.17
Interest	0.36	0.59	0.41	0.69	0.39	2.13	0.63	0.95	1.39	1.81
Depreciation	0.69	0.64	0.65	0.66	0.71	-0.23	0.85	0.86	0.86	-0.24
Profit Before Tax	-3.55	-2.59	-2.82	-2.77	-4.96	-3.80	-8.15	-6.44	-6.33	-1.28
Tax %	-6.48	409.27	51.42	-2.89	20.77	43.42	25.03	23.45	23.38	-32.81
Net Profit	-3.78	8.02	-1.36	-2.85	-3.93	-2.15	-6.11	-4.93	-4.84	-1.70
EPS in Rs	-0.85	2.21	-0.35	-0.75	1.07	-0.60	-1.65	-1.33	-1.32	-0.45

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	8.15	13	21	14	52	61	31	40	109	112
Expenses	13	17	23	22	48	59	38	49	119	127
Operating Profit	-4.84	-4.00	-2.04	-7.87	3.84	1.48	-7.12	-9.70	-9.94	-15
OPM %	-59.39	-31.06	-9.96	-57.36	7.39	2.44	-22.97	-24.46	-9.10	-13.44
Other Income	0.62	1.36	0.31	4.02	2.28	0.55	-0.72	0.08	1.04	1.18
Interest	0.60	0.90	0.75	1.09	1.78	0.92	1.49	1.59	1.78	3.84
Depreciation	0.90	0.94	1.02	1.00	1.20	1.59	2.05	2.66	0.82	1.99
Profit Before Tax	-5.72	-4.48	-3.49	-5.94	3.14	-0.49	-11	-14	-12	-20
Tax %	-1.49	-1.08	6.84	2.58	6.81	-24.75	-1.74	74.92	16.19	23.58
Net Profit	-5.81	-4.53	-3.25	-5.79	2.93	-0.61	-12	-3.48	-9.68	-15
EPS in Rs	-1.57	-1.22	-0.88	-1.56	0.79	-0.21	-3.13	-0.82	-0.63	-4.75
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10	10	10	14	14	33	37
Reserves	-32	-38	-42	-45	-51	-48	-49	-60	-54	-62
Borrowings	17	18	18	21	26	48	52	68	57	62
Other Liabilities	25	28	31	35	34	24	14	32	26	46
Total Liabilities	20	19	17	21	19	34	31	54	63	83
Fixed Assets	13	12	12	12	11	16	20	28	29	40
CWIP	0.07	0.43	0.06	0.00	0.00	0.65	0.34	0.00	0.00	0.23
Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Other Assets	6.85	6.14	4.57	9.21	7.15	17	11	26	34	44
Total Assets	20	19	17	21	19	34	31	54	63	83

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.85	0.52	1.28	-7.79	-2.59	-1.62	-1.68	-1.63	-13	2.60
Cash from Investing Activity	-2.08	-0.90	-0.39	-0.56	-0.50	-6.72	-4.94	-9.64	-4.09	-11
Cash from Financing Activity	1.17	0.39	-0.90	8.36	3.19	8.67	6.33	11	17	8.67
Net Cash Flow	-0.06	0.01	-0.01	0.01	0.10	0.33	-0.29	-0.05	-0.01	0.02

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	26.80%	29.73%	29.73%	29.73%	33.69%	53.28%	51.12%	51.12%	57.92%	57.95%	55.93%	56.54%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Public	73.18%	70.25%	70.25%	70.25%	66.29%	46.69%	48.85%	48.85%	42.06%	42.02%	44.04%	43.44%
Total Shareholders	8,987	8,972	9,051	10,102	9,970	10,154	10,111	10,030	10,094	10,179	10,215	10,205

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd (OXYGENTAPH) is currently trading at 49.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Oxygenta Pharmaceutical Limited, formerly S S Organics Ltd, specializes in manufacturing anti-ulcerative and antibacterial drugs, alongside other pharmaceuticals. The company engages in both contract manufacturing and independent production, supporting its revenue through strategic partnerships. Oxygenta's production facilities are situated in Medak, Andhra Pradesh, focusing on bulk drugs, including quinolones, antiasthmatic, and anti-inflammatory medications. Despite operational challenges, such as the 2015 fire accident, Oxygenta has resumed commercial production to stabilize its operations and market position.

Over the past 52 weeks, Oxygenta Pharmaceutical Ltd has traded between a low of ₹45.30 and a high of ₹133.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Oxygenta Pharmaceutical Ltd has a market capitalization of approximately 185.77. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Oxygenta Pharmaceutical Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -10.57 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 185.77 Cr, Oxygenta Pharmaceutical Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Oxygenta Pharmaceutical Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Oxygenta Pharmaceutical Ltd is -10.57. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Oxygenta Pharmaceutical Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Oxygenta Pharmaceutical Ltd

What is Oxygenta Pharmaceutical Ltd share price today?

What does Oxygenta Pharmaceutical Ltd do?

What is the 52-week high and low of Oxygenta Pharmaceutical Ltd?

What is the market capitalization of Oxygenta Pharmaceutical Ltd?

Should I consider investing in Oxygenta Pharmaceutical Ltd stock?

Is Oxygenta Pharmaceutical Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Oxygenta Pharmaceutical Ltd belong to and why does it matter?

What is the PE ratio of Oxygenta Pharmaceutical Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Oxygenta Pharmaceutical Ltd

What is Oxygenta Pharmaceutical Ltd share price today?

What does Oxygenta Pharmaceutical Ltd do?

What is the 52-week high and low of Oxygenta Pharmaceutical Ltd?

What is the market capitalization of Oxygenta Pharmaceutical Ltd?

Should I consider investing in Oxygenta Pharmaceutical Ltd stock?

Is Oxygenta Pharmaceutical Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Oxygenta Pharmaceutical Ltd belong to and why does it matter?

What is the PE ratio of Oxygenta Pharmaceutical Ltd?

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Announcements

Overview

Financial Ratios

Investment Checklist